Dashboard
Manage Tickers

NRIXNurix Therapeutics, Inc.

Nasdaq nurixtx.com


$ 21.95 $ 0.39 (1.81 %)    

Wednesday, 14-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.74 $ 0.15 (0.03 %)
DIA $ 400.12 $ 2.30 (0.58 %)
SPY $ 543.85 $ 1.71 (0.32 %)
TLT $ 97.88 $ 0.61 (0.63 %)
GLD $ 226.19 $ -1.86 (-0.82 %)
$ 21.92
$ 21.92 x 100
-- x --
-- - --
$ 4.22 - $ 24.38
561,245
na
1.37B
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-11-2024 05-31-2024 10-Q
2 04-10-2024 02-29-2024 10-Q
3 02-15-2024 11-30-2023 10-K
4 10-12-2023 08-31-2023 10-Q
5 07-13-2023 05-31-2023 10-Q
6 04-13-2023 02-28-2023 10-Q
7 02-09-2023 11-30-2022 10-K
8 10-06-2022 08-31-2022 10-Q
9 07-07-2022 05-31-2022 10-Q
10 04-08-2022 02-28-2022 10-Q
11 01-28-2022 11-30-2021 10-K
12 10-14-2021 08-31-2021 10-Q
13 07-13-2021 05-31-2021 10-Q
14 04-13-2021 02-28-2021 10-Q
15 02-16-2021 11-30-2020 10-K
16 10-14-2020 08-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tjx-to-rally-over-15-here-are-10-top-analyst-forecasts-for-wednesday
TJX To Rally Over 15%? Here Are 10 Top Ana...
08/14/2024 11:43:04

oppenheimer-maintains-outperform-on-nurix-therapeutics-raises-price-target-to-27
Oppenheimer Maintains Outperform on Nurix ...
08/14/2024 11:22:17

Oppenheimer analyst Mark Breidenbach maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and raises the price targe...

forecasting-the-future-13-analyst-projections-for-nurix-therapeutics
Forecasting The Future: 13 Analyst Project...
07/31/2024 15:01:34

truist-securities-initiates-coverage-on-nurix-therapeutics-with-buy-rating-announces-price-target-of-36
Truist Securities Initiates Coverage On Nu...
07/31/2024 14:23:07

Truist Securities analyst Srikripa Devarakonda initiates coverage on Nurix Therapeutics (NASDAQ:NRIX) with a Buy rating and ...

analyst-scoreboard-12-ratings-for-nurix-therapeutics
Analyst Scoreboard: 12 Ratings For Nurix T...
07/15/2024 15:00:42

jp-morgan-maintains-overweight-on-nurix-therapeutics-raises-price-target-to-34
JP Morgan Maintains Overweight on Nurix Th...
07/15/2024 13:56:33

JP Morgan analyst Eric Joseph maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and raises the price target from ...

barclays-maintains-overweight-on-nurix-therapeutics-raises-price-target-to-31
Barclays Maintains Overweight on Nurix The...
07/15/2024 13:04:05

Barclays analyst Peter Lawson maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and raises the price target from ...

rbc-capital-maintains-outperform-on-nurix-therapeutics-raises-price-target-to-27
RBC Capital Maintains Outperform on Nurix ...
07/12/2024 14:56:30

RBC Capital analyst Gregory Renza maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and raises the price target f...

needham-maintains-buy-on-nurix-therapeutics-lowers-price-target-to-29
Needham Maintains Buy on Nurix Therapeutic...
07/12/2024 10:12:45

Needham analyst Gil Blum maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $31 to $29.

nurix-says-enters-h2-of-2024-well-positioned-to-develop-lead-clinical-program-nx-5948-into-pivotal-clinical-trials-in-chronic-lymphocytic-leukemia-in-2025
Nurix Says Enters H2 Of 2024 Well Position...
07/11/2024 20:06:53

Cash, cash equivalents and marketable securities was $452.5 million as of May 31, 2024, compared to $254.3 million as of Februa...

nurix-therapeutics-q2-2024-gaap-eps-071-misses-063-estimate-sales-12092m-miss-22105m-estimate
Nurix Therapeutics Q2 2024 GAAP EPS $(0.71...
07/11/2024 20:02:07

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of ...

expert-outlook-nurix-therapeutics-through-the-eyes-of-14-analysts
Expert Outlook: Nurix Therapeutics Through...
06/27/2024 15:00:49

rbc-capital-maintains-outperform-on-nurix-therapeutics-raises-price-target-to-26
RBC Capital Maintains Outperform on Nurix ...
06/27/2024 14:30:48

RBC Capital analyst Gregory Renza maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and raises the price target f...

nvidia-to-rally-around-53-here-are-10-top-analyst-forecasts-for-tuesday
Nvidia To Rally Around 53%? Here Are 10 To...
06/18/2024 13:44:27

hc-wainwright--co-maintains-buy-on-nurix-therapeutics-raises-price-target-to-26
HC Wainwright & Co. Maintains Buy on Nurix...
06/18/2024 10:10:20

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price targ...

whats-going-on-with-small-cap-cancer-focused-nurix-therapeutics-on-monday
What's Going On With Small-Cap Cancer Focu...
06/17/2024 15:47:08

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-59...

jp-morgan-maintains-overweight-on-nurix-therapeutics-raises-price-target-to-31
JP Morgan Maintains Overweight on Nurix Th...
06/17/2024 14:09:15

JP Morgan analyst Eric Joseph maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and raises the price target from ...

why-nurix-therapeutics-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Nurix Therapeutics Shares Are Trading ...
06/17/2024 12:43:16

nurix-therapeutics-shares-are-trading-higher-after-the-company-announced-results-from-its-ongoing-clinical-trial-of-nx-5948-in-patients-with-relapsed-refractory-chronic-lymphocytic-leukemia
Nurix Therapeutics shares are trading high...
06/17/2024 11:32:53

needham-reiterates-buy-on-nurix-therapeutics-maintains-31-price-target
Needham Reiterates Buy on Nurix Therapeuti...
06/17/2024 09:49:28

Needham analyst Gil Blum reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $31 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION